Rheumatoid arthritis: From autoimmunity to synovitis and joint destruction

Journal of Autoimmunity

Volumn 39, Issue 3, 2012, Pages 222-228

  Boissier, Marie Christophe ^a,b   Semerano, Luca ^a,b   Challal, Salima ^a,b   Saidenberg Kermanac'h, Nathalie ^a,b   Falgarone, Géraldine ^a,b  

^a Université Paris 13   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Chronic inflammation; Citrullination; Cytokines; Rheumatoid arthritis; TNF inhibition

Indexed keywords

AUTOANTIGEN; CD20 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6 RECEPTOR; OSTEOPROTEGERIN; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; AUTOIMMUNITY; B LYMPHOCYTE; DENDRITE; GENE LOCUS; GENOTYPE ENVIRONMENT INTERACTION; HUMORAL IMMUNITY; INNATE IMMUNITY; JOINT DESTRUCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; OSTEOCLAST; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TOBACCO; WNT SIGNALING PATHWAY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; CYTOKINES; HUMANS; JOINTS; LYMPHOCYTE ACTIVATION; OSTEOCLASTS; RHEUMATOID FACTOR; SYNOVITIS; TH1 CELLS; TH17 CELLS;

EID: 84865375172     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.05.021     Document Type: Review

References (59)

1. Boissier M.C. Cell and cytokine imbalances in rheumatoid synovitis. Jt Bone Spine 2011, 78:230-234.
2. MacGregor A.J., Snieder H., Rigby A.S., Koskenvuo M., Kaprio J., Aho K., et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000, 43:30-37.
3. Silman A.J., MacGregor A.J., Thomson W., Holligan S., Carthy D., Farhan A., et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993, 32:903-907.
4. Goronzy J.J., Weyand C.M. Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res Ther 2009, 11:249.
5. Bottini N., Vang T., Cucca F., Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 2006, 18:207-213.
6. Klareskog L., Ronnelid J., Lundberg K., Padyukov L., Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008, 26:651-675.
7. Klareskog L., Stolt P., Lundberg K., Kallberg H., Bengtsson C., Grunewald J., et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006, 54:38-46.
8. Iobagiu C., Magyar A., Nogueira L., Cornillet M., Sebbag M., Arnaud J., et al. The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted. J Autoimmun 2011, 37:263-272.
9. Mahdi H., Fisher B.A., Kallberg H., Plant D., Malmstrom V., Ronnelid J., et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009, 41:1319-1324.
10. Wegner N., Wait R., Sroka A., Eick S., Nguyen K.A., Lundberg K., et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 2010, 62:2662-2672.
11. Auger I., Balandraud N., Rak J., Lambert N., Martin M., Roudier J. New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA. Ann Rheum Dis 2009, 68:591-594.
12. Fujii H., Shao L., Colmegna I., Goronzy J.J., Weyand C.M. Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci USA 2009, 106:4360-4365.
13. Rantapaa-Dahlqvist S., de Jong B.A., Berglin E., Hallmans G., Wadell G., Stenlund H., et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2741-2749.
14. Karlson E.W., Chibnik L.B., Tworoger S.S., Lee I.M., Buring J.E., Shadick N.A., et al. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum 2009, 60:641-652.
15. Weyand C.M., Kurtin P.J., Goronzy J.J. Ectopic lymphoid organogenesis: a fast track for autoimmunity. Am J Pathol 2001, 159:787-793.
16. Zhang Z., Gorman C.L., Vermi A.C., Monaco C., Foey A., Owen S., et al. TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues. Blood 2007, 109:4328-4335.
17. Semerano L., Clavel G., Assier E., Denys A., Boissier M.C. Blood vessels, a potential therapeutic target in rheumatoid arthritis?. Jt Bone Spine 2011, 78:118-123.
18. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999, 56:794-814.
19. Eklund L., Olsen B.R. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 2006, 312:630-641.
20. Amano T., Yamasaki S., Yagishita N., Tsuchimochi K., Shin H., Kawahara K., et al. Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev 2003, 17:2436-2449.
21. Lefevre S., Knedla A., Tennie C., Kampmann A., Wunrau C., Dinser R., et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009, 15:1414-1420.
22. Lee D.M., Kiener H.P., Agarwal S.K., Noss E.H., Watts G.F., Chisaka O., et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 2007, 315:1006-1010.
23. Sfikakis P.P. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr Dir Autoimmun 2010, 11:180-210.
24. Jacob C.O., McDevitt H.O. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature 1988, 331:356-358.
25. Yang X.D., Tisch R., Singer S.M., Cao Z.A., Liblau R.S., Schreiber R.D., et al. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med 1994, 180:995-1004.
26. Nadkarni S., Mauri C., Ehrenstein M.R. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med 2007, 204:33-39.
27. Biton J., Semerano L., Delavallee L., Lemeiter D., Laborie M., Grouard-Vogel G., et al. Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis. J Immunol 2011, 186:3899-3910.
28. Chen X., Baumel M., Mannel D.N., Howard O.M., Oppenheim J.J. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol 2007, 179:154-161.
29. Biton J., Boissier M.C., Bessis N. TNFalpha: activator or inhibitor of regulatory T cells?. Jt Bone Spine 2012, 79:119-123.
30. Bessis N., Guery L., Mantovani A., Vecchi A., Sims J.E., Fradelizi D., et al. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis. Eur J Immunol 2000, 30:867-875.
31. Chizzolini C., Dayer J.M., Miossec P. Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?. Arthritis Res Ther 2009, 11:246.
32. Arend W.P., Palmer G., Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008, 223:20-38.
33. Gabay C., McInnes I.B. The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases. Arthritis Res Ther 2009, 11:230.
34. Kim S.H., Han S.Y., Azam T., Yoon D.Y., Dinarello C.A. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005, 22:131-142.
35. Palmer G., Talabot-Ayer D., Lamacchia C., Toy D., Seemayer C.A., Viatte S., et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 2009, 60:738-749.
36. Assier E., Boissier M.C., Dayer J.M. Interleukin-6: from identification of the cytokine to development of targeted treatments. Jt Bone Spine 2010, 77:532-536.
37. Knupfer H., Preiss R. sIL-6R: more than an agonist?. Immunol Cell Biol 2008, 86:87-91.
38. Boissier M.C., Chiocchia G., Bessis N., Hajnal J., Garotta G., Nicoletti F., et al. Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur J Immunol 1995, 25:1184-1190.
39. Steinman L. Mixed results with modulation of TH-17 cells in human autoimmune diseases. Nat Immunol 2010, 11:41-44.
40. Duvallet E., Semerano L., Assier E., Falgarone G., Boissier M.C. Interleukin-23: a key cytokine in inflammatory diseases. Ann Med 2011, 43:503-511.
41. Ratsimandresy R.A., Duvallet E., Assier E., Semerano L., Delavallee L., Bessis N., et al. Active immunization against IL-23p19 improves experimental arthritis. Vaccine 2011, 29:9329-9336.
42. Quintero O.L., Amador-Patarroyo M.J., Montoya-Ortiz G., Rojas-Villarraga A., Anaya J.M. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 2012, 38:J109-J119.
43. Wing K., Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010, 11:7-13.
44. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
45. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
46. Behrens M., Smart M., Luckey D., Luthra H., Taneja V. To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice. J Autoimmun 2011, 37:95-103.
47. Rezzonico R., Burger D., Dayer J.M. Direct contact between T lymphocytes and human dermal fibroblasts or synoviocytes down-regulates types I and III collagen production via cell-associated cytokines. J Biol Chem 1998, 273:18720-18728.
48. Burger D., Dayer J.M. The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction. Arthritis Res 2002, 4(Suppl. 3):S169-S176.
49. Lipsky P.E. Rheumatoid arthritis. Harrison's principles of internal medicine 2005, 1968-1977. McGraw-Hill, New York. 16th ed. D.L. Kasper, E. Braunwald, A.S. Fauci, S.L. Hauser, D.L. Longo, J.L. Jameson (Eds.).
50. Lipsky P.E. Why does rheumatoid arthritis involve the joints?. N Engl J Med 2007, 356:2419-2420.
51. Chabaud M., Aarvak T., Garnero P., Natvig J.B., Miossec P. Potential contribution of IL-17-producing Th(1)cells to defective repair activity in joint inflammation: partial correction with Th(2)-promoting conditions. Cytokine 2001, 13:113-118.
52. Polzer K., Diarra D., Zwerina J., Schett G. Inflammation and destruction of the joints-the Wnt pathway. Jt Bone Spine 2008, 75:105-107.
53. Saidenberg-Kermanac'h N., Bessis N., Lemeiter D., de Vernejoul M.C., Boissier M.C., Cohen-Solal M. Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis. J Clin Immunol 2004, 24:370-378.
54. Jimenez-Boj E., Redlich K., Turk B., Hanslik-Schnabel B., Wanivenhaus A., Chott A., et al. Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis. J Immunol 2005, 175:2579-2588.
55. Hetland M.L., Ejbjerg B., Horslev-Petersen K., Jacobsen S., Vestergaard A., Jurik A.G., et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis 2009, 68:384-390.
56. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011, 365:2205-2219.
57. Youinou P., Haralampos M. Moutsopoulos: a lifetime in autoimmunity. J Autoimmun 2010, 35:171-175.
58. Mackay I.R., Leskovsek N.V., Rose N.R. The odd couple: a fresh look at autoimmunity and immunodeficiency. J Autoimmun 2010, 35:199-205.
59. Gershwin M.E., Shoenfeld Y. Chella David: a lifetime contribution in translational immunology. J Autoimmun 2011, 37:59-62.